GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,756.20p
   
  • Change Today:
      36.60p
  • 52 Week High: 1,810.40
  • 52 Week Low: 1,380.40
  • Currency: UK Pounds
  • Shares Issued: 5,084m
  • Volume: 6,252,376
  • Market Cap: £89,286m
  • RiskGrade: 129

GSK Overview

UK-based GSK Plc is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GSK Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%
31-Dec-20 34,099.00 6,968.00 115.90p 11.6 n/a -6% 80.00p 6.0%
31-Dec-21 34,114.00 5,442.00 113.20p 14.2 n/a -2% 80.00p 5.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 35,973.33 8,416.04 120.92p 14.5 2.1 +7% 52.27p 3.1%
31-Dec-23 37,021.55 9,230.30 129.46p 13.6 1.9 +7% 53.98p 3.2%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

GSK Company Announcements

Director/PDMR Shareholding 24-Jun-2022 15:44 RNS
Director/PDMR Shareholding 16-Jun-2022 10:58 RNS
Positive phase III data for GSK’s RSV OA v... 10-Jun-2022 07:00 RNS

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
23-Jun-22 Buy Urs Rohner 1,691.00p 610 £10,315.10
23-Jun-22 Buy Jesse Goodman 1,697.32p 668 £11,338.10
23-Jun-22 Buy Laurie Glimcher 1,697.32p 2,024 £34,353.77

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,756.20p
Change Today 36.60p
% Change 2.13 %
52 Week High 1,810.40
52 Week Low 1,380.40
Volume 6,252,376
Shares Issued 5,084m
Market Cap £89,286m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
76.25% above the market average76.25% above the market average76.25% above the market average76.25% above the market average76.25% above the market average
87.30% above the sector average87.30% above the sector average87.30% above the sector average87.30% above the sector average87.30% above the sector average
Income Not Available
Growth
69.68% below the market average69.68% below the market average69.68% below the market average69.68% below the market average69.68% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 12
Sell 0
Strong Sell 1
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 19-May-22 24-Feb-22
Paid 01-Jul-22 07-Apr-22
Amount 14.00p 23.00p

Trades for 24-Jun-2022

Time Volume / Share Price
16:45 16,734 @ 1,753.00p
16:45 16,734 @ 1,753.00p
16:41 300,000 @ 1,751.76p
16:39 1,000 @ 1,756.20p
16:39 14,000 @ 1,756.20p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page